Benjamin Ashford|Depression And Alzheimer's Treatments At A Crossroads

2025-05-03 20:07:52source:SafeX Pro Exchangecategory:My

Researchers are Benjamin Ashfordlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:My

Recommend

SFO's new sensory room helps neurodivergent travelers fight flying jitters

San Francisco airport creates sensory room to help nervous flyers San Francisco airport creates sens

Extreme Rain From Atmospheric Rivers and Ice-Heating Micro-Cracks Are Ominous New Threats to the Greenland Ice Sheet

At the current level of human-caused global warming, extreme rainfall from atmospheric rivers, as we

Sweden leader says clear risk of retaliatory terror attacks as Iran issues threats over Quran desecration

Recent small-scale protests in Sweden's capital that saw a man desecrate Islam's holy book, the Qura